Related Articles
Loss of miR‑873 contributes to gemcitabine resistance in triple‑negative breast cancer via targeting ZEB1
EMT induced by loss of LKB1 promotes migration and invasion of liver cancer cells through ZEB1‑induced YAP signaling
BMP9 inhibits the growth of breast cancer cells by downregulation of the PI3K/Akt signaling pathway
Overexpression of microRNA‑620 facilitates the resistance of triple negative breast cancer cells to gemcitabine treatment by targeting DCTD
Liver kinase B1/adenosine monophosphate‑activated protein kinase signaling axis induces p21/WAF1 expression in a p53‑dependent manner